What’s in a name? That which we call a rose by any other name would smell as sweet.
No doubt. But a name also is an aspiration.
It is with that preface that I am pleased to share a bit of news that arrived with my July Drug Information Journal – the publication (the official journal of the DIA) is changing its name.
Transparency Alert: I am an Associate Editor of this journal.
The new title, Therapeutic Innovation & Regulatory Science, is a stake in the ground. First, it’s not just about “drugs.” That’s a great leap forward. Second, it’s about innovation. That’s where the action is. And third, it’s not about regulation, but rather “regulatory science.” That’s a global topic -- from the FDA’s Critical Path initiative to the EMA’s IMI and beyond. And, dare we hope – one that might some day lead to greater harmonization.
Like I said – a name is also aspirational.
Bon Courage, Therapeutic Innovation & Regulatory Science!
Our aspirations are our possibilities.
-- Samuel Johnson
